Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07143474

Effect of RhizomK on Testosterone Levels, the Anabolic Response to Exercise and Overall Quality of Life in Physically Active Healthy Males

A Randomized Double-blind Placebo Controlled Clinical Study to Evaluate the Impacts of RhizomK as Compared to Placebo on Testosterone Levels, the Anabolic Response to Exercise and Overall Quality of Life in Physically Active Healthy Males

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
All India Institute of Medical Sciences, Bhubaneswar · Academic / Other
Sex
Male
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

Given that testosterone is a key modulator of muscle protein synthesis and overall anabolic response to resistance training, any natural intervention that boosts testosterone levels could logically contribute to improved exercise performance, lean muscle gain, and subjective vitality. 13 However, despite encouraging preclinical and ethnopharmacological data, clinical validation of Curculigo extract in human participants-especially in the context of exercise and lifestyle enhancement-is lacking. A novel extract of Curculigo orchioides (commercially known as RhizomK™) has been developed. This randomized, double-blind, placebo-controlled study seeks to bridge this crucial gap by evaluating the efficacy and safety of RhizomK™ supplementation in healthy, physically active males. The findings of this study have the potential to substantiate RhizomK™ as a scientifically supported dietary intervention for enhancing hormonal balance, physical performance, and well-being in men who are not candidates for pharmacological therapy but are seeking to optimize their health through lifestyle and supplementation.

Conditions

Interventions

TypeNameDescription
DRUGRhizomKRhizomK 50 mg once daily
OTHERPlceboPlacebo matching to RhizomK

Timeline

Start date
2025-10-01
Primary completion
2026-10-01
Completion
2027-02-01
First posted
2025-08-27
Last updated
2025-09-04

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT07143474. Inclusion in this directory is not an endorsement.